Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy
Background. Hypertrophic cardiomyopathy (HCM) has different complications such as cardiac arrhythmia and sudden cardiac death (SCD). Insertion of an implantable cardioverter defibrillator (ICD) is recommended for HCM patients who are at high risk of SCD and malignant arrhythmias, despite having thei...
Saved in:
| Main Authors: | Mohammad Taghi Hedayati Goudarzi, Maryam Moradi, Saeed Abrotan, Mehrdad Saravi, Hoda Shirafkan, Rana Irilouzadian, Hossein Salehi Omran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2023/4552100 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of cardiac resynchronization therapy with implantable cardioverter defibrillators on patients with moderate to severe chronic heart failure: A single-arm clinical trial
by: Hossein Salehi Omran, et al.
Published: (2025-03-01) -
Transvenous versus subcutaneous implantable cardioverter defibrillator for hypertrophic cardiomyopathy: A meta-analysis
by: Xi Yang, et al.
Published: (2025-08-01) -
Clinical, morphological and genetic characteristics of young patients with hypertrophic cardiomyopathy with indications for implantable cardioverter-defibrillator
by: V. G. Davydova, et al.
Published: (2024-12-01) -
A Pregnancy with Severe Hypertrophic Obstructive Cardiomyopathy after Surgery for an Implantable Cardioverter Defibrillator: A Case Report and Literature Review
by: Takashi Mitsui, et al.
Published: (2016-01-01) -
Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators
by: Kotaro Nishino, et al.
Published: (2025-08-01)